Skip to main content
. 2024 Jul 15;16(7):943. doi: 10.3390/pharmaceutics16070943

Figure 4.

Figure 4

Anti-tumor potency and efficacy of 8F2-SG3199 in xenograft model of SKNAS cells. (A) Growth curves of tumors treated with vehicle, 8F2-SG3199, or R20-SG3199 at the indicated dose levels. Days of the five injections were marked by arrows. (B) Body weight curves. (C) Kaplan–Meier survival plot.